
|Poll|February 8, 2022
POLL: Which AD comorbidities were most interesting?
Author(s)Dermatology Times Staff
Click to answer this week's poll on the newly released AAD guidelines on AD comorbidites.
Advertisement
The AAD has recently released guidlines on AD and its association with other conditions. Which section was more intriguing to you?
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
2
Medicus Pharma Completes Phase 2 Enrollment of D-MNA Study to Non-Invasively Treat BCC
3
Phase 2 Nemolizumab Trial Opens for CPUO
4
Transformative Advances This Year and Beyond
5


















